Clarcor, Inc. (CLC) Misses Q2 EPS by 1c; Lowers FY13 EPS Outlook
Tweet
Share
E-mailGet Alerts CLC Hot Sheet
Price: $83.00 --0%
Financial Fact:
Interest expense: -1.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: -1.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Clarcor, Inc. (NYSE: CLC) reported Q2 EPS of $0.66, $0.01 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $287.6 million versus the consensus estimate of $290.19 million.
Clarcor, Inc. sees FY2013 EPS of $2.45-2.55, versus prior guidance of $2.45-2.60 and the consensus of $2.56.
For earnings history and earnings-related data on Clarcor, Inc. (CLC) click here.
Clarcor, Inc. sees FY2013 EPS of $2.45-2.55, versus prior guidance of $2.45-2.60 and the consensus of $2.56.
For earnings history and earnings-related data on Clarcor, Inc. (CLC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
